The global anatomic pathology market value was US$ 16.08 billion in 2020. The global pathology market value is forecast to reach US$ 45.6 billion by 2030, growing at a compound annual growth rate (CAGR) of 11% during the forecast period from 2021-2030.
The process of anatomic pathology involves the processing, examination, and diagnosis of surgical specimens by a physician trained in pathology. In hospitals, anatomic pathologies investigate the effects of disease on the human body by conducting autopsies and microscopic examinations of cells, tissues, and other specimens. Laboratory administrators are responsible for the quality and accuracy of the laboratory tests performed on samples of tissues and fluids. Pathologists work in community hospitals and in academic medical centers where they provide patient care, diagnostic testing, and research.
Factors Influencing Market Growth
Impact Analysis of COVID-19
In collaboration with governments across the globe, pharmaceutical and biotech firms are developing vaccines and planning for challenges of the global medicine supply chain related to the COVID-19 outbreak. COVID-19 has seen a dramatic surge in demand for commonly used drugs such as Hydroxychloroquine. Due to the high demand for these drugs, COVID-19 management drugs have presented tremendous opportunities for manufacturers, as many developed countries are short on them. These factors resulted in significant growth for COVID 19 in the Anatomic pathology market.
Regional Insights
Region-wise, North America generated the most revenue in 2020. It's because major players and supportive government initiatives exist to train pathologists. As a result of favorable reimbursement policies in the U.S., tissue-diagnostic related procedures have gained prominence in disease screening. Furthermore, the approval and commercialization of products in the region have contributed to the market growth.
Growing demand for advanced imaging modalities, improved patient care facilities, and several pathology labs franchising their operations fuel the growth of the Asia Pacific market. Public agencies like the Pathology Branch of the Chinese Medical Association in China, which assists pathology projects, contribute to the fastest growth of the APAC market.
Leading Competitors
The leading prominent companies profiled in the global anatomic pathology market are:
Scope of the Report
The global anatomic pathology market segmentation focuses on Product and Services, Application, End Users, and Regions.
Segmentation based on Product and Services
Segmentation based on Application
Segmentation based on End Users
Segmentation based on Regions
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL ANATOMIC PATHOLOGY MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL ANATOMIC PATHOLOGY MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL ANATOMIC PATHOLOGY MARKET, BY PRODUCT AND SERVICES
5.1 OVERVIEW
5.2 SERVICES
5.2.1 HISTOPATHOLOGY
5.2.2 CYTOPATHOLOGY
5.3 INSTRUMENTS
5.3.1 SLIDE STAINING SYSTEMS
5.3.2 TISSUE PROCESSING SYSTEMS
5.3.3 CELL PROCESSORS
5.3.4 MICROTOMES
5.3.5 EMBEDDED SYSTEMS
5.3.6 COVERSLIPPERS
5.3.7 OTHERS
5.4 CONSUMABLES
5.4.1 ANTIBODIES
5.4.1.1 PRIMARY ANTIBODIES
5.4.1.2 SECONDARY ANTIBODIES
5.4.2 KITS & REAGENTS
5.4.2.1 STAINS & SOLVENTS
5.4.2.2 FIXATIVES
5.4.2.3 OTHERS
5.5 PROBES
5.6 OTHER CONSUMABLES
6 GLOBAL ANATOMIC PATHOLOGY MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 DISEASE DIAGNOSIS
6.3 CANCER
6.3.1 BREAST CANCER
6.3.2 LUNG CANCER
6.3.3 GASTROINTESTINAL CANCER
6.3.4 PROSTATE CANCER
6.3.5 OTHERS
6.4 MEDICAL RESEARCH
7 GLOBAL ANATOMIC PATHOLOGY MARKET, BY END-USER
7.1 OVERVIEW
7.2 HOSPITAL LABORATORIES
7.3 CLINICAL LABORATORIES
7.4 OTHER END USERS
8 GLOBAL ANATOMIC PATHOLOGY MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL ANATOMIC PATHOLOGY MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
10 COMPANY PROFILES
10.1 AGILENT TECHNOLOGIES, INC.
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.2 BIO SB
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.3 BIOGENEX
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.4 CARDINAL HEALTH
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.5 DANAHER CORPORATION
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.6 F. HOFFMANN-LA ROCHE AG
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.7 LABORATORY CORPORATION OF AMERICA HOLDINGS
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.8. NEOGENOMICS LABORATORIES, INC.
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.9 PHC HOLDINGS CORPORATION
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.10 QUEST DIAGNOSTICS INCORPORATED
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.11 SAKURA FINETEK USA, INC.
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
We Accept
Copyright ©2022 All rights reserved
